395 results on '"Maltais, S."'
Search Results
102. 37 Tricuspid Valve Insufficiency in Patients with Axial-flow Left Ventricular Assist Devices
103. 299 Functional Exhaustion of Bone Marrow-Derived Endothelial Progenitor Cells in a Chronic Swine Model of Myocardial Ischemia
104. (935) - Does Identifying Patients That Need Inpatient Rehabilitation After Continuous-Flow Left Ventricular Assist Device Placement Improve Outcomes?
105. (623) - Long-Term Valvular Function and Outcomes Following Left Ventricular Assist Device Implantation: Is an Aggressive Approach Warranted?
106. (567) - Does the Utilization of a Temporary External Anchoring Suture Increase the Risk of Driveline Infection After Implantation of a Left Ventricular Assist Device
107. (563) - Do Warfarin Polymorphisms (VKORC1 and CYP2C9) Influence Maintenance Anticoagulation Variability in Patients With Continuous Flow Left Ventricular Assist Devices?
108. (519) - Update on Post-Approval INTERMACs Registry of the HVAD System in Commercial Use
109. (429) - INTERMACS Profiles: Heterogeneity of LVAD Patient Classification
110. (396) - Outcomes of Patients Receiving Temporary Circulatory Support Prior to Durable LVAD
111. (394) - Initial Outcomes of the Left Thoracotomy Technique for a Miniaturized Centrifugal Continuous-Flow Pump Compare Favorably to a Conventional Sternotomy
112. (329) - Partial Support for Bridged Patients With Previous Cardiac Surgery Implanted With a Miniaturized Centrifugal Continuous-Flow Pump: Are We There Yet?
113. (310) - A Comprehensive Analysis of Hospital Charges Between Direct Heart Transplantation and Patients Bridged With a Left Ventricular Assist Device
114. (279) - Treatment of Device Thrombus in the HeartWare HVAD: Success and Outcomes Depend Significantly on Initial Treatment Strategy
115. (284) - Discriminatory Power of Commonly Used Indices and Scores in Predicting Early Severe Right Ventricular Failure After Continuous-Flow Left Ventricular Assist Device Implantation
116. (156) - Percutaneous Driveline Infection Does Not Increase Subsequent Risk of Stroke and Pump Thrombus During Support With a Left Ventricular Assist Device
117. (149) - Right Ventricular Adaptation to Afterload Worsens Up to 6 Months After LVAD Implantation But Improves Over Time
118. (132) - Does Indication for Destination Therapy Affect Left Ventricular Assist Device Outcomes?
119. (105) - Influence of Liver Dysfunction in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation: Comparative Analysis Using the MELD Excluding INR (MELD-XI) Scoring System
120. (95) - Temporal Differences in Adverse Event Rates in Patients Bridged With the HeartWare Left Ventricular Assist Device
121. (91) - Neurological Events in Patients Bridged to Long-Term Mechanical Circulatory Support: A Device Specific Comparative Analysis
122. (53) - Does Device Type Differentially Influence Pulmonary Vascular Resistance in Patients Bridged to Transplantation With a Continuous Flow Left Ventricular Assist Device?
123. (6) - Temporal Analysis of Outcomes During Long-Term Mechanical Circulatory Support: An Initial Report From the Mechanical Circulatory Support Research Network
124. (3) - A Multi-Institutional Outcome Analysis of Patients Undergoing Left Ventricular Assist Device Implantation Stratified By Sex and Race
125. Preliminary experience with inhaled milrinone in cardiac surgery☆
126. Effect of tetrahydrobiopterin on selective endothelial dysfunction of epicardial porcine coronary arteries induced by cardiopulmonary bypass
127. (662) - Can the Severity of Post-operative Bleeding Events be Predicted from Von Willebrand Factor Dysfunction in Continuous Flow Left Ventricular Assist Device Recipients?
128. (631) - Does Postoperative Improvement in Brain Natriuretic Peptide Predict Readmission after Left Ventricular Assist Device?
129. (629) - RNAseq Identifies Novel Potential Right Ventricular Biomarkers in Human Heart Failure
130. (261) - Readmission after Left Ventricular Assist Device Implantation: Differences Observed Between Two Device Types
131. (195) - Chronic Intravenous Milrinone as a Bridge to Cardiac Transplantation Does Not Improve Pulmonary Arterial Compliance
132. (142) - Can a Minimally Invasive OFF-pump Implantation Strategy be Considered Safe for Selected Patients Undergoing HeartWare Ventricular Assist Device Implantation?
133. (135) - Limited Efficacy of Milrinone as a Bridge to Cardiac Transplantation in the Current Era
134. (74) - Does Preoperative Mitral Regurgitation Influence Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation?
135. (83) - HeartWare Ventricular Assist Device Implantation: Are In-Hospital Outcomes Using a Minimally Invasive Thoracotomy Approach Comparable to Conventional Sternotomy?
136. (79) - First Report of the PAS INTERMACs Registry of the HVAD in Commercial Use
137. (75) - Does Metabolic Syndrome Affect Outcomes After Left Ventricular Assist Device Implantation?
138. (41) - Can We Define a Device-specific Profile for Acquired Von Willebrand Syndrome in Continuous Flow Left Ventricular Assist Device Recipients?
139. (19) - Gender and Race Association with Tacrolimus (CYP3A5) and Simvastatin (SLOCO1B1) Polymorphisms in an Adult Heart Transplant Population
140. RXR acts as a coregulator in the regulation of genes of the hypothalamo-pituitary axis by thyroid hormone receptors
141. The neurogenic origin of hypertension in SHR may be mediated by angiotensin II through a receptor different from AT1 and AT2
142. Cellular Colocalization of Dopamine D1 mRNA and D2 Receptor in Rat Brain Using a D2 Dopamine Receptor Specific Polyclonal Antibody
143. Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys
144. (1050) - Does INTERMACS Classification Predict Outcomes after LVAD Implantation?
145. (719) - Retained Blood Syndrome Impacts Outcomes after Left Ventricular Assist Device Implantation.
146. (233) - A Novel, Highly Discriminatory Risk Model Predicting Acute Severe Right Ventricular Failure in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implant.
147. (675) - The Effect of Preoperative Serum Iron Levels on Thromboembolic Events after Left Ventricular Assist Device Implantation.
148. (83) - Lessons Learned from over 250 Continuous-Flow Centrifugal Left Ventricular Assist Device Implantation: Growing Experience and Outcomes in Alternative Approaches Era.
149. (391) - Differential Assessment of von Willebrand Factor Dysfunction in Durable Mechanical Circulatory Support: A Plead for Standardization.
150. (424) - PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management (PREVENT).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.